In this context, previous findings, together with our results, which collectively reveal differential expression of HIF-1α and HIF-2α between CNS-HBs and RCC, suggest that therapeutic strategies targeting the HIF system should consider isoform-specific expression patterns in each VHL-associated tumor type. The gene discussed is VHL; the disease is renal cell carcinoma.